A Study of PER-001 in Participants With Diabetic Retinopathy

Clinical trial NCT06003751 · COMPLETED

Trial details

NCT number: NCT06003751
Sponsor: Perfuse Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2023-08-05
Primary completion: 2025-04-03
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.